{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:37:20Z","timestamp":1768829840776,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-03998-7","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T02:01:25Z","timestamp":1709776885000},"page":"2495-2502","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antimicrobial prophylaxis protocol based on rectal swab culture before prostate biopsy to prevent infectious complications: a prospective randomized comparative study"],"prefix":"10.1007","volume":"56","author":[{"given":"A.","family":"Bouzouita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-1976","authenticated-orcid":false,"given":"A.","family":"Rehaiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zaghbib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chakroun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Derouiche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. Boutiba-Ben","family":"Boubaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R. Ben","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"6","key":"3998_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3998_CR2","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/s0090-4295(02)01958-1","volume":"60","author":"R Raaijmakers","year":"2002","unstructured":"Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60(5):826\u2013830. https:\/\/doi.org\/10.1016\/s0090-4295(02)01958-1","journal-title":"Urology"},{"issue":"6","key":"3998_CR3","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.eururo.2008.03.033","volume":"54","author":"AM Bootsma","year":"2008","unstructured":"Bootsma AM, Laguna Pes MP, Geerlings SE, Goossens A (2008) Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol 54(6):1270\u20131286. https:\/\/doi.org\/10.1016\/j.eururo.2008.03.033","journal-title":"Eur Urol"},{"issue":"2","key":"3998_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.urology.2011.02.065","volume":"78","author":"B Akduman","year":"2011","unstructured":"Akduman B, Akduman D, Tokg\u00f6z H, Erol B, T\u00fcrker T, Ayo\u011flu F, Mungan NA (2011) Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology 78(2):250\u2013255. https:\/\/doi.org\/10.1016\/j.urology.2011.02.065","journal-title":"Urology"},{"issue":"1","key":"3998_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.urology.2008.12.067","volume":"74","author":"E Ozden","year":"2009","unstructured":"Ozden E, Bostanci Y, Yakupoglu KY, Akdeniz E, Yilmaz AF, Tulek N, Sarikaya S (2009) Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology 74(1):119\u2013123. https:\/\/doi.org\/10.1016\/j.urology.2008.12.067","journal-title":"Urology"},{"issue":"6","key":"3998_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.juro.2014.06.005","volume":"192","author":"MA Liss","year":"2014","unstructured":"Liss MA, Taylor SA, Batura D, Steensels D, Chayakulkeeree M, Soenens C, Rao GG, Dash A, Park S, Patel N, Woo J, McDonald M, Nseyo U, Banapour P, Unterberg S, Ahlering TE, Van Poppel H, Sakamoto K, Fierer J, Black PC (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192(6):1673\u20131678. https:\/\/doi.org\/10.1016\/j.juro.2014.06.005","journal-title":"J Urol"},{"issue":"6","key":"3998_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1111\/j.1464-410X.2012.11637.x","volume":"111","author":"S Taylor","year":"2013","unstructured":"Taylor S, Margolick J, Abughosh Z, Goldenberg SL, Lange D, Bowie WR, Bell R, Roscoe D, Machan L, Black P (2013) Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int 111(6):946\u2013953. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11637.x","journal-title":"BJU Int"},{"issue":"2","key":"3998_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/nrurol.2013.322","volume":"11","author":"FM Wagenlehner","year":"2014","unstructured":"Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014) Reducing infection rates after prostate biopsy. Nat Rev Urol 11(2):80\u201386. https:\/\/doi.org\/10.1038\/nrurol.2013.322","journal-title":"Nat Rev Urol"},{"issue":"12","key":"3998_CR9","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00345-015-1571-y","volume":"33","author":"SJ Summers","year":"2015","unstructured":"Summers SJ, Patel DP, Hamilton BD, Presson AP, Fisher MA, Lowrance WT, Southwick AW (2015) An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. World J Urol 33(12):2001\u20132007. https:\/\/doi.org\/10.1007\/s00345-015-1571-y","journal-title":"World J Urol"},{"issue":"58","key":"3998_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2340\/sju.v58.11920","volume":"8","author":"M Holmbom","year":"2023","unstructured":"Holmbom M, Forsberg J, Fredrikson M, Nilsson M, Nilsson LE, Hanberger H, H\u00e4llgren A (2023) Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Scand J Urol 8(58):32\u201337. https:\/\/doi.org\/10.2340\/sju.v58.11920","journal-title":"Scand J Urol"},{"issue":"3","key":"3998_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s11845-021-02723-y","volume":"191","author":"E Benli","year":"2022","unstructured":"Benli E, Yuce A, Cirakoglu A, Yazici I, Kadim N, Nalbant I (2022) Effect of targeted prophylaxis with rectal swab on complications after prostate biopsy: prospective randomized study. Ir J Med Sci 191(3):1147\u20131152. https:\/\/doi.org\/10.1007\/s11845-021-02723-y","journal-title":"Ir J Med Sci"},{"issue":"5","key":"3998_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","volume":"35","author":"KG Naber","year":"2003","unstructured":"Naber KG, S\u00f6rgel F (2003) Antibiotic therapy\u2013rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 35(5):331\u2013335","journal-title":"Andrologia"},{"issue":"4","key":"3998_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/s0090-4295(98)00296-9","volume":"52","author":"DA Kapoor","year":"1998","unstructured":"Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graham E, Echols RM, Whalen E, Kowalsky SF (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52(4):552\u2013558. https:\/\/doi.org\/10.1016\/s0090-4295(98)00296-9","journal-title":"Urology"},{"key":"3998_CR14","unstructured":"G. Bonkat (Chair), R. Bartoletti, F. Bruy\u00e8re, T. Cai, S.E. Geerlings, B. K\u00f6ves, S. Schubert, F. Wagenlehner, Guidelines Associates: T. Mezei, A. Pilatz, B. Pradere, R. Veeratterapillay . EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam the Netherlands 2020. ISBN 978\u201394\u201392671\u201307\u20133."},{"issue":"5","key":"3998_CR15","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.urology.2010.12.067","volume":"77","author":"OM Zaytoun","year":"2011","unstructured":"Zaytoun OM, Vargo EH, Rajan R, Berglund R, Gordon S, Jones JS (2011) Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Urology 77(5):1035\u20131041. https:\/\/doi.org\/10.1016\/j.urology.2010.12.067","journal-title":"Urology"},{"issue":"3","key":"3998_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s0924-8579(00)00182-5","volume":"15","author":"F Wagenlehner","year":"2000","unstructured":"Wagenlehner F, St\u00f6wer-Hoffmann J, Schneider-Brachert W, Naber KG, Lehn N (2000) Influence of a prophylactic single dose of ciprofloxacin on the level of resistance of Escherichia coli to fluoroquinolones in urology. Int J Antimicrob Agents 15(3):207\u2013211. https:\/\/doi.org\/10.1016\/s0924-8579(00)00182-5","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3998_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.11.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care. J Urol 187(4):1275\u20131279. https:\/\/doi.org\/10.1016\/j.juro.2011.11.115","journal-title":"J Urol"},{"issue":"3","key":"3998_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.urology.2011.09.057","volume":"79","author":"CA Duplessis","year":"2012","unstructured":"Duplessis CA, Bavaro M, Simons MP, Marguet C, Santomauro M, Auge B, Collard DA, Fierer J, Lesperance J (2012) Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology 79(3):556\u2013561. https:\/\/doi.org\/10.1016\/j.urology.2011.09.057","journal-title":"Urology"},{"issue":"4","key":"3998_CR19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","volume":"185","author":"MA Liss","year":"2011","unstructured":"Liss MA, Chang A, Santos R, Nakama-Peeples A, Peterson EM, Osann K, Billimek J, Szabo RJ, Dash A (2011) Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 185(4):1283\u20131288. https:\/\/doi.org\/10.1016\/j.juro.2010.11.088","journal-title":"J Urol"},{"issue":"9","key":"3998_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1086\/671734","volume":"34","author":"N Suwantarat","year":"2013","unstructured":"Suwantarat N, Dumford DM 3rd, Ponce-Terashima R, Kundrapu S, Zabarsky TF, Zhu H, Donskey CJ (2013) Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy. Infect Control Hosp Epidemiol 34(9):973\u2013976. https:\/\/doi.org\/10.1086\/671734","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"3998_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.urology.2014.09.035","volume":"85","author":"J Dai","year":"2015","unstructured":"Dai J, Leone A, Mermel L, Hwang K, Pareek G, Schiff S, Golijanin D, Renzulli JF 2nd (2015) Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study. Urology 85(1):8\u201314. https:\/\/doi.org\/10.1016\/j.urology.2014.09.035","journal-title":"Urology"},{"issue":"1","key":"3998_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.urology.2014.07.078","volume":"85","author":"JH Tsu","year":"2015","unstructured":"Tsu JH, Ma WK, Chan WK, Lam BH, To KC, To WK, Ng TK, Liu PL, Cheung FK, Yiu MK (2015) Prevalence and predictive factors of harboring fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase-producing rectal flora in Hong Kong Chinese men undergoing transrectal ultrasound-guided prostate biopsy. Urology 85(1):15\u201321. https:\/\/doi.org\/10.1016\/j.urology.2014.07.078","journal-title":"Urology"},{"issue":"1","key":"3998_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12941-021-00487-y","volume":"20","author":"K Piekarska","year":"2021","unstructured":"Piekarska K, Zacharczuk K, Wo\u0142kowicz T, Mokrzy\u015b M, Wolaniuk N, Nowakowska M, Szempli\u0144ski S, Dobruch J, Gierczy\u0144ski R (2021) The molecular mechanisms of fluoroquinolone resistance found in rectal swab isolates of Enterobacterales from men undergoing a transrectal prostate biopsy: the rationale for targeted prophylaxis. Ann Clin Microbiol Antimicrob 20(1):81. https:\/\/doi.org\/10.1186\/s12941-021-00487-y","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"3998_CR24","first-page":"261","volume":"32","author":"\u00dc Tekdo\u011fan","year":"2006","unstructured":"Tekdo\u011fan \u00dc, Tuncel A, Ero\u011flu M, \u00dcnsal A, Atan A, Balbay MD (2006) The efficiency of prophylactic antibiotic treatment in patients without risk factor who underwent transrectal. T\u00fcrk \u00dcroloji Dergisi 32(2):261\u2013267","journal-title":"T\u00fcrk \u00dcroloji Dergisi"},{"issue":"7","key":"3998_CR25","first-page":"496","volume":"10","author":"H Wang","year":"2004","unstructured":"Wang H, Zhou X, Chen S, Zhu C, Yu X (2004) Investigation of infection risk and the value of antibiotic prophylaxis during transrectal biopsy of the prostate by endotoxin determination. Zhonghua Nan Ke Xue 10(7):496\u2013498","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"3","key":"3998_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.juro.2012.08.237","volume":"189","author":"EO Kehinde","year":"2013","unstructured":"Kehinde EO, Al-Maghrebi M, Sheikh M, Anim JT (2013) Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol 189(3):911\u2013915. https:\/\/doi.org\/10.1016\/j.juro.2012.08.237","journal-title":"J Urol"},{"issue":"2","key":"3998_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.juro.2012.08.194","volume":"189","author":"M Adibi","year":"2013","unstructured":"Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y (2013) Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 189(2):535\u2013540. https:\/\/doi.org\/10.1016\/j.juro.2012.08.194","journal-title":"J Urol"},{"issue":"5","key":"3998_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.urology.2014.06.052","volume":"84","author":"W Song","year":"2014","unstructured":"Song W, Choo SH, Sung HH, Han DH, Jeong BC, Seo SI, Jeon SS, Lee KS, Lee SW, Lee HM, Choi HY, Jeon HG (2014) Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy. Urology 84(5):1001\u20131007. https:\/\/doi.org\/10.1016\/j.urology.2014.06.052","journal-title":"Urology"},{"issue":"5","key":"3998_CR29","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.urology.2014.04.060","volume":"84","author":"E Tukenmez Tigen","year":"2014","unstructured":"Tukenmez Tigen E, Tandogdu Z, Ergonul O, Altinkanat G, Gunaydin B, Ozgen M, Sariguzel N, Erturk Sengel B, Odabasi Z, Cek M, Tokuc R, Turkeri L, Mulazimoglu L, Korten V (2014) Outcomes of fecal carriage of extended-spectrum \u03b2-lactamase after transrectal ultrasound-guided biopsy of the prostate. Urology 84(5):1008\u20131015. https:\/\/doi.org\/10.1016\/j.urology.2014.04.060","journal-title":"Urology"},{"issue":"7","key":"3998_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/cid\/ciac913","volume":"76","author":"SCM Tops","year":"2023","unstructured":"Tops SCM, Kolwijck E, Koldewijn EL, Somford DM, Delaere FJM, van Leeuwen MA, Breeuwsma AJ, de Vocht TF, Broos HJHP, Schipper RA, Steffens MG, Teerenstra S, Wegdam-Blans MCA, de Brauwer E, van den Bijllaardt W, Leenders ACAP, Sedelaar JPM, Wertheim HFL (2023) Rectal culture-based versus empirical antibiotic prophylaxis to prevent infectious complications in men undergoing transrectal prostate biopsy: a randomized. Nonblinded Multicent Trial Clin Infect Dis 76(7):1188\u20131196. https:\/\/doi.org\/10.1093\/cid\/ciac913","journal-title":"Nonblinded Multicent Trial Clin Infect Dis"},{"issue":"6","key":"3998_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.urology.2011.07.1392","volume":"78","author":"S Minamida","year":"2011","unstructured":"Minamida S, Satoh T, Tabata K, Kimura M, Tsumura H, Kurosaka S, Matsumoto K, Fujita T, Iwamura M, Baba S (2011) Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy. Urology 78(6):1235\u20131239. https:\/\/doi.org\/10.1016\/j.urology.2011.07.1392","journal-title":"Urology"},{"issue":"6","key":"3998_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1469-0691.2011.03638.x","volume":"18","author":"D Steensels","year":"2012","unstructured":"Steensels D, Slabbaert K, De Wever L, Vermeersch P, Van Poppel H, Verhaegen J (2012) Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy\u2013should we reassess our practices for antibiotic prophylaxis. Clin Microbiol Infect 18(6):575\u2013581. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03638.x","journal-title":"Clin Microbiol Infect"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-03998-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-03998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:36:07Z","timestamp":1721792167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-03998-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-03998-7","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"18 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for this study protocol, the patient information sheet, and the informed consent form were approved by the local Ethics Committee of the Charles Nicolle Hospital: CHN Ethics Committee member of the Office for the Protection of Human Research (OHRP) in the United States recognized under the number FWA:FWA00032748\/IID:IORG0011243.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The study involves Humans Participants and has been carried out in accordance with the ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"All patients undergoing TRUS-BP were included following informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}